IV particles lead to drug recall

February 25, 2009

Email this news item to a friend/colleague Email this news item to a friend/colleague

Intravenous news: Health Canada, the federal agency that regulates the country’s healthcare delivery, is recalling lots of a drug used to treat iron and aluminum toxicity in dialysis patients due to the possibility of tiny particles forming after the drug is prepared for intravenous administration.

Health Canada said it is working with manufacturer Hospira Healthcare Corp. in recalling certain lots of Desferrioxamine Mesilate for Injection, which treats acute or chronic iron toxicity and chronic aluminum overload in dialysis patients with end-stage renal disease. The formation of particles in the affected lots might produce cloudiness after preparation. These particles can block small blood vessels after injection.

The following are being recalled: Lot U072231AA in a 500-mg format and Lot U102237AA in a 2-g format. The lot number is on the label of the carton as well as on the vial.

Click here for the full story.

More IV news at IVTEAM

Other stories

Written by IVTEAM · Filed Under All, IV Alert, IV News 

Add IVTEAM to Technorati Favorites del.icio.us:IV particles lead to drug recall digg:IV particles lead to drug recall spurl:IV particles lead to drug recall wists:IV particles lead to drug recall simpy:IV particles lead to drug recall newsvine:IV particles lead to drug recall blinklist:IV particles lead to drug recall furl:IV particles lead to drug recall reddit:IV particles lead to drug recall fark:IV particles lead to drug recall blogmarks:IV particles lead to drug recall Y!:IV particles lead to drug recall smarking:IV particles lead to drug recall magnolia:IV particles lead to drug recall segnalo:IV particles lead to drug recall gifttagging:IV particles lead to drug recall

Comments

Please leave a comment?